Wolverine contains BPC-157 and TB-500. The references examine its individual components; they do not directly evaluate the finished VIVO blend.
Wolverine is a two-component research blend containing BPC-157 and TB-500. No peer-reviewed study located in this evidence review evaluated the VIVO blend as a combined material. The references below therefore address the identity, detection, metabolism, and cell-level activity reported for its individual components.
For BPC-157, analytical studies have used mass spectrometry to identify the parent sequence and related fragments formed under controlled in vitro conditions. For the thymosin beta-4-derived component, laboratory work has examined actin binding and the effect of an LKKTETQ-containing peptide on endothelial-cell migration and tube formation.
These sources provide a practical basis for component verification and experimental design. They should not be read as evidence of synergy, compatibility, stability, or a predictable combined response for Wolverine. Those questions require direct study of the finished blend under a defined protocol.
Peer-reviewed sources for the research summarised above. VIVO summarises published, third-party science and does not conduct or sponsor this research.